C3‐dependent effector functions of complement

A Zarantonello, M Revel, A Grunenwald… - Immunological …, 2023 - Wiley Online Library
C3 is the central effector molecule of the complement system, mediating its multiple
functions through different binding sites and their corresponding receptors. We will introduce …

Pro-inflammatory actions of heme and other hemoglobin-derived DAMPs

MT Bozza, V Jeney - Frontiers in Immunology, 2020 - frontiersin.org
Damage associated molecular patterns (DAMPs) are endogenous molecules originate from
damaged cells and tissues with the ability to trigger and/or modify innate immune responses …

Sickle cell disease: role of oxidative stress and antioxidant therapy

R Vona, NM Sposi, L Mattia, L Gambardella, E Straface… - Antioxidants, 2021 - mdpi.com
Sickle cell disease (SCD) is the most common hereditary disorder of hemoglobin (Hb),
which affects approximately a million people worldwide. It is characterized by a single …

[HTML][HTML] Thromboinflammatory mechanisms in sickle cell disease–challenging the hemostatic balance

N Conran, EV De Paula - Haematologica, 2020 - ncbi.nlm.nih.gov
Sickle cell disease (SCD) is an inherited hemoglobinopathy that is caused by the presence
of abnormal hemoglobin S (HbS) in red blood cells, leading to alterations in red cell …

Complement biology for hematologists

A Duval, V Frémeaux‐Bacchi - American Journal of …, 2023 - Wiley Online Library
The complement system is part of the innate immunity. An increased activation or a loss of
the regulation of this fine‐tuned cascade is involved in a variety of hematological diseases …

MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease

JD Belcher, J Nguyen, C Chen, F Abdulla… - Translational …, 2022 - Elsevier
Patients with sickle cell disease (SCD) have ongoing hemolysis that promotes endothelial
injury, complement activation, inflammation, vaso-occlusion, ischemia-reperfusion …

[HTML][HTML] The molecular basis for the prothrombotic state in sickle cell disease

AS Shet, MA Lizarralde-Iragorri, RP Naik - Haematologica, 2020 - ncbi.nlm.nih.gov
The genetic and molecular basis of sickle cell disease (SCD) has long been characterized
but the pathophysiological basis has not been entirely defined. How a red cell hemolytic …

Autoimmune disease and sickle cell anaemia:'Intersecting pathways and differential diagnosis'

A Piccin, N O'Connor‐Byrne, M Daves… - British Journal of …, 2022 - Wiley Online Library
Sickle cell disease (SCD) is an inherited disorder, which occurs due to a single gene
mutation. It has multisystemic manifestations, affecting millions of people worldwide. The …

Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing

A Tampaki, E Gavriilaki, C Varelas, A Anagnostopoulos… - Blood Reviews, 2021 - Elsevier
Sickle cell disease (SCD) is a common inherited clinical syndrome, characterized by the
presence of hemoglobin S. Anemia, susceptibility to infections and episodes of vaso …

How I treat sickle cell disease in pregnancy

AH James, JJ Strouse - Blood, 2024 - ashpublications.org
Fifty years ago, people with sickle cell disease (SCD) were discouraged from becoming
pregnant, but now, most should be supported if they choose to pursue a pregnancy. They …